期刊文献+

MR DWI在Graves病病情评估中的应用 被引量:5

Application of MR DWI in evaluating the severity of Graves disease
暂未订购
导出
摘要 目的探讨MR DWI在Graves病病情评估中的价值。方法对82例经临床确诊的活动期Graves病患者及15名健康受试者行DWI,b值取0和1000s/mm2,分别测量甲状腺两侧叶中部水平的ADC值;比较不同病情活动期Graves病甲状腺实质的ADC值的差异;对ADC值与甲状腺功能指标(FT3、FT4、TSH和24h摄碘率)进行相关性检验。结果不同病情活动期Graves病的ADC值差异有统计学意义(F=16.57,P<0.01),两两比较差异亦有统计学意义(P均<0.05);Graves病甲状腺实质ADC值与血清FT3(r=0.40,P<0.01)、FT4(r=0.31,P<0.01)均呈正相关,与TSH及24h吸碘率无相关性(P>0.05)。结论 DWI在Graves病病情评估中具有一定指导作用。 Objective To investigate the value of MR diffusion weighted imaging (DWI) in evaluating the severity of ac tive Graves disease. Methods DWI with b value 0 and 1000 s/ram2 was performed in 82 patients with clinically diagnosed active Graves disease and 15 healthy volunteers. Apparent diffusion coefficient (ADC) values of bilateral lobes at middle portions were measured. The differences were analyzed between different groups. Correlation analysis was performed a mong ADC values and thyroid functional laboratory test serum free triiodothyronine (FT3), free thyroxine (FT4), thyroid stimulating hormone (TSH) and 24 hours" thyroid radioiodide uptake (RAIU). Results There was statistical difference a- mong different severities (F= 16.57, P〈0.01), multiple comparisons between any two groups also displayed statistical differences (all P〈0. 05). ADC values had positive correlation with serum FT3 (r= 0. 40, P〈0.01), FT4 (r= 0.31, P〈0. 01), but had no correlation with TSH and 24 hours" thyroid RAIU (P〈O. 05). Conclusion DWI is helpful to evaluating the severity of active Graves disease.
出处 《中国医学影像技术》 CSCD 北大核心 2012年第11期1977-1981,共5页 Chinese Journal of Medical Imaging Technology
关键词 扩散磁共振成像 表观扩散系数 甲状腺疾病 Diffusion magnetic resonance imaging Apparent diffusion coefficient Thyroid disease
  • 相关文献

参考文献13

  • 1蒋宁一,匡安仁,谭建,陆汉魁,林岩松,丁虹,张永学.131I治疗Graves甲亢专家共识(2010年)[J].中华核医学杂志,2010,30(5):346-351. 被引量:117
  • 2Thoeny HC, De Keyzer F. Extracranial applications of diffusion- weighted magnetic resonance imaging. Eur Radiol, 2007, 17(6) : 1385-1393.
  • 3Thoeny HC, De Keyzer F, King AD. Diffusion-weighted Mr ima- ging in the head and neck. Radiology, 2012,263(1):19-32,.
  • 4Tezuka M, Murata Y, Ishida R, et al. MR imaging of the thy- roid: correlation between apparent diffusion coefficient and thy- roid gland scintigraphy. J Magn Reson Imaging, 2003, 17 (2): 163-169.
  • 5Bozgeyik Z, Coskun S, Dagli AF, et al. Diffusion-weighted MR imaging of thyroid nodules. Neuroradiology, 2009,51 (3) : 193- 198.
  • 6Erdem G, Erdem T, Muammer H, et al. Diffusion-weighted ima- ges differentiate benign from malignant thyroid nodules. J Magn Reson Imaging, 2010,31(1) :94-100.
  • 7Mutlu H, Sivrioglu AK, Sonmez G, et al. Role of apparent diffu- sion coefficient values and diffusion-weighted magnetic resonance imaging in differentiation between benign and malignant thyroid nodules. Clin Imaging, 2012,36(1) : 1-7.
  • 8Abdel Razek AA, Sadek AG, Gaballa G. Diffusion-weighed MR of the thyroid gland in Graves" disease: Assessment of disease ac- tivity and prediction of outcome. Acad Radiol, 2010, 17(6) :779- 783.
  • 9Koh DM, Collins DJ, Orton MR. Intravoxel incoherent motion in body diffusion-weighted MRI: Reality and challenges. AJR Am J Roentgenol, 2011,196(6) : 1351-1361.
  • 10practice BC. Graves" disease. N Engl J Med, 2008, 358(24): 2594-2605.

二级参考文献6

共引文献116

同被引文献67

  • 1陆再英;钟南山;谢毅.内科学[M]{H}北京:人民卫生出版社,2008712-722.
  • 2Tezuka M,Murata Y,Ishida R. MR imaging of the thyroid:correlation between apparent diffusion coefifcient and thyroid:gland scintigraphy[J].{H}Journal of Magnetic Resonance Imaging,2003,(2):163-169.
  • 3Bozgeyik Z,Coskun S,Dagli AF. Diffusion-weighted imaging of the thyroid nodules[J].{H}NEURORADIOLOGY,2009,(3):193-198.
  • 4Erdem G,Erdem T,Muammer H. Diffusion-weighted images differentiate benign from malignant thyroid nodules[J].{H}Journal of Magnetic Resonance Imaging,2010,(1):94-100.
  • 5Mutlu H,Sivrioglu AK,Sonmez G. Role of apparent diffusion coefifcient values and diffusion-weighted magnetic resonance imaging in differentiation between benign and malignant thyroid nodules[J].{H}Clinical Imaging,2012,(1):1-7.
  • 6Abdel Razek AA,Sadek AG,Gaballa G. Diffusion-weighted MR of the thyroid gland in Graves' disease:assessment of disease activity and prediction of outcome[J].{H}ACADEMIC RADIOLOGY,2010,(6):779-783.
  • 7Intenzo CM, Dam HQ, Manzone TA, et al. Imaging of the thyroid inbenign and malignant disease[J]. Semin Nucl Med,2012,42:49-61.
  • 8Hoang JK, Branstetter BF 4th, Gafton AR, et al. Imaging of thyroidcarcinoma with ct and mri: approaches to common scenarios[J]. Can-cer Imaging,2013,13:128-139.
  • 9Mutlu H, Sivrioglu AK, Sonmez G, et al. Role of apparent difiusioncoefficient values and diffusion-weighted magnetic resonance imag-ing in differentiation between benign and malignant thyroid nodules[J]. Clin imaging,2012,36:1-7.
  • 10Sinkus R, Bernard E. Beers V, et al. Apparent diffusion coefficientfrom magnetic resonance imaging as a biomarker in oncology drugdevelopment[J].Eur J Cancer,2012,48:425-431.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部